Celine Goldberger Selected Research

alpha- ((5- fluoro- 2- methoxyphenyl)methyl)- alpha- (tetrahydro- 2H- pyran- 4- yl)- 2- morpholinemethanol

1/2017	Is the Noradrenergic Symptom Cluster a Valid Construct in Adjunctive Treatment of Major Depressive Disorder?
5/2016	Efficacy outcomes from 3 clinical trials of edivoxetine as adjunctive treatment for patients with major depressive disorder who are partial responders to selective serotonin reuptake inhibitor treatment.
6/2015	Long-Term, Open-Label, Safety Study of Edivoxetine 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment.
6/2015	Edivoxetine compared to placebo as adjunctive therapy to selective serotonin reuptake inhibitors in the prevention of symptom re-emergence in major depressive disorder.
1/2015	Safety and tolerability of edivoxetine as adjunctive treatment to selective serotonin reuptake inhibitor antidepressants for patients with major depressive disorder.
1/2014	A double-blind, placebo-controlled study of edivoxetine as an adjunctive treatment for patients with major depressive disorder who are partial responders to selective serotonin reuptake inhibitor treatment.
6/2011	A randomized, double-blind study comparing LY2216684 and placebo in the treatment of major depressive disorder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Celine Goldberger Research Topics

Disease

8	Major Depressive Disorder (Major Depressive Disorders) 01/2017 - 06/2010
1	Syndrome (Syndromes) 01/2017
1	Erectile Dysfunction 01/2014
1	Fatigue 01/2014
1	Hyperhidrosis 01/2014
1	Pain (Aches) 01/2014
1	Nausea 01/2014
1	Schizophrenia (Dementia Praecox) 08/2005

Drug/Important Bio-Agent (IBA)

7	alpha- ((5- fluoro- 2- methoxyphenyl)methyl)- alpha- (tetrahydro- 2H- pyran- 4- yl)- 2- morpholinemethanolIBA 01/2017 - 06/2011
6	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2017 - 06/2011
5	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 05/2016 - 01/2014
3	Antidepressive Agents (Antidepressants)IBA 06/2015 - 06/2010
1	Dopamine D3 ReceptorsIBA 08/2005
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 08/2005

Therapy/Procedure

2	Therapeutics 05/2016 - 06/2015